Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596267 · ClinicalTrials.gov registry record · Phase 1
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
A Phase 1 study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT04596267 is a Phase 1 study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT04596267, a Phase 1 study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a double-blind, randomized, placebo-controlled, crossover design trial that will test the effect of pitolisant on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this proposal is to determine whether pitolisant has effects on alcohol consumption and craving
Interventions
- DRUG Placebo
- DRUG Pitolisant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2023-02-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04596267
The ClinicalTrials.gov registry entry for NCT04596267 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04596267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04596267 about?
NCT04596267 is a clinical study titled "Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers". This is a double-blind, randomized, placebo-controlled, crossover design trial that will test the effect of pitolisant on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this proposal is to determine whether pitolisant has effects on alcohol con...
What is the current status of trial NCT04596267?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2021-09-13. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT04596267?
The interventions under investigation include: Placebo (DRUG), Pitolisant (DRUG).
Who is sponsoring clinical trial NCT04596267?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.